Attorneys from Banville Law report on a lawsuit filed against defendants AbbVie Inc. and Abbott Laboratories in relation to their prescription testosterone medication AndroGel.
In this specific complaint - filed under case 1:14-cv-00777 - the plaintiff was prescribed AndroGel and used the drug as prescribed for symptoms which he attributed to low testosterone.
The plaintiff filed the lawsuit after suffering a Transient Ischemic Attack (TIA) or “mini-stroke” which he claims was caused as a result of his exposure to AndroGel. A Transient Ischemic Attack is caused by a temporary blood clot and is often referred to as a “warning stroke” because approximately one in every three people who experience a TIA end up suffering a major stroke within a year. Prior to his use of the testosterone medication AndroGel, the plaintiff had no history of this type of cardiac event or other related events.
This lawsuit is part of the Multidistrict Litigation (MDL 2454) pending in the US District Court for the Northern District of Illinois under Judge Matthew F. Kennelly. The MDL currently includes more than 2,000 lawsuits relating to dangerous events which have been associated with various prescription testosterone replacement therapy supplements.
In addition to other claims, case 1:14-cv-00777 alleges that the AndroGel supplied was defective due to inadequate warnings about the risks associated with the prescription which the company either knew about or should have known about.
The complaint also claims that defendants AbbVie Inc. and Abbott Laboratories acted fraudulently by willfully deceiving consumers and physicians by intentionally concealing information about the dangers of AndroGel which the defendants had a duty to disclose.
Testosterone Attorneys: Pursuing Justice For Plaintiffs in “Low T” Litigation
More lawsuits are being filed in the testosterone MDL every day as people learn about the allegations against pharmaceutical companies. “If you or loved one suffered serious injury after using a testosterone replacement therapy supplement you may have grounds for a lawsuit,” commented Laurence Banville, Esq. of Banville Law.
“We are currently assisting individuals and families throughout the country wishing to file a lawsuit in the pending litigation,” Banville continued.
For more information, please visit LowTestosteroneCase.com or contact Laurence Banville, Esq. at 888-478-9711.
Banville Law is a New York law firm dedicated to assisting plaintiffs in lawsuits involving personal injury, product liability and related legal matters.
165 West End Avenue, #1H
New York, NY 10023
United States (US)
April 29, 2016 – Risperdal Lawsuit Allegations Draw Concern Over Possible Gynecomastia Side Effect
April 29, 2016 – Mother Files Risperdal Lawsuit Claiming Drug Caused Development Of Son’s Gynecomastia
April 29, 2016 – Risperdal Plaintiff Awarded $1.75 Million In Damages
April 28, 2016 – Risperdal Lawsuit Plaintiffs Are Awarded $8 Million After The Death Of A Family Member
April 28, 2016 – Millions Awarded To Plaintiffs In Risperdal Lawsuit Verdicts
April 28, 2016 – Risperdal Lawsuit Trial Draws Attention To Controversial Testimony And Potentially Hidden Study Results
April 27, 2016 – Risperdal Lawsuit Plaintiffs Observe As Millions Paid Out For Risperdal Jury Verdicts
April 27, 2016 – Louisiana Risperdal Lawsuit Plaintiff Claims Drug Caused Son’s Gynecomastia Development
April 27, 2016 – U.S. Supreme Court Shows Favor To Risperdal Lawsuit Plaintiffs
April 26, 2016 – Johnson & Johnson Subsidiary Janssen Pharmaceuticals Loses Third Risperdal Lawsuit